TEM5 regulated VEGF-induced tumor angiogenic processes in vitro including cell-cell interaction, permeability, migration, invasion, and tube formation [74]. In vitro study showed that knockdown of TEM5 in non-small cell lung cancer (NSCLC) reduces resistance to gefitinib [75]. This evidence concerns the gene VEGFA and neoplasm.